Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914108 · ClinicalTrials.gov registry record · NA
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00914108 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 30 participants.
The verdict
NCT00914108, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about the development of small for gestational age (SGA) preterm infants and whether focusing on the infant's behavior has a positive effect on outcome. The study hypotheses state: 1) High risk severely SGA preterm infants will profit from detailed neuropsychological assessment, psychoeducational recommendations and practical guidance for caregiving, as well as formal educational and emotional support for the family and the professional care team. 2) Neuropsychological education and guidance for community-based early intervention providers caring for SGA preterm infants after their discharge is effective in promoting improved outcome.
Interventions
- BEHAVIORAL Newborn Individualized Developmental Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1996-10 |
| Est. Completion | 2002-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00914108
The ClinicalTrials.gov registry entry for NCT00914108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Newborn Individualized Developmental Care is the first listed.
NCT00914108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00914108 about?
NCT00914108 is a clinical study titled "Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care". The purpose of the study is to learn more about the development of small for gestational age (SGA) preterm infants and whether focusing on the infant's behavior has a positive effect on outcome. The study hypotheses state: 1) High risk severely SGA preterm infants will profit from detailed neuropsyc...
What is the current status of trial NCT00914108?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 1996-10. Estimated completion is 2002-07.
What interventions are being tested in trial NCT00914108?
The interventions under investigation include: Newborn Individualized Developmental Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00914108?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.